AEON Stapler

Discussion in 'Covidien' started by anonymous, Aug 6, 2018 at 1:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Does anybody know anything about this? One of my hospitals asked me, saying they have reloads that work on our handles. Doesn't sound legit to me.
     

  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

  4. anonymous

    anonymous Guest


    Good luck. Your technology has been around forever and is likely off patent. They're not going to go to all the trouble to create something that sits on them. They'll use technology in the public domain. Nothing you can do about it.
     
  5. anonymous

    anonymous Guest

    Dear Customer,

    Congratulations on the cost savings you are achieving with Aeon Surgical reloads. As reward for your wisdom, Medtronic will be granting you list price on everything you can’t buy from Aeon, which is A LOT.

    Love,

    Omar
     
  6. anonymous

    anonymous Guest

    Dearest Omar,

    In sincere appreciation for your arrogance, we will be moving the balance of our endomechanical business to Ethicon and Applied. As a special token of our appreciation we will be moving our pacing and AICD business to Boston Scientific, our Structural Heart and TAVR business to Edwards and our spine business to Stryker.

    If you would like to reconsider leveraging your portfolio against this small piece of business, we may be willing to re-open discussions.

    Warm regards,

    VP Supply Chain
     
  7. anonymous

    anonymous Guest

    Good luck with that.
     
  8. anonymous

    anonymous Guest

    Typical supply chain thinking...stepping over dollars to pick up dimes.
     
  9. anonymous

    anonymous Guest

    I think you might have that backwards. You'd be very short sighted to not understand that this will be a full line, low cost competitor within 2-3years. Open, Endo and circular.

    Remember what Applied did to trocar pricing and margins? There is very strong probability that Lexington (or whoever buys them, cough cough Applied, Stryker, Teleflex) will cause the same disruption in stapling.
     
  10. anonymous

    anonymous Guest

    Applied would be an excellent buyer for Lexington. Their existing customer base already prioritizes cost over quality and would probably be more willing to risk using an aftermarket reload with an OEM handle.
     
  11. anonymous

    anonymous Guest

    Strangely, the FDA, the most stringent medical regulatory body in the world, felt the "risk" was small enough to clear for sale.

    Quit your fear mongering and work on an explanation why HUGOroboto is going to be launched in India first.
     
  12. anonymous

    anonymous Guest

    There’s an interesting film about how that “stringent regulatory body” approves med devices....

    https://m.youtube.com/watch?v=slmilObZl28
     
  13. anonymous

    anonymous Guest

    There are two avenues for FDA approval, PMA and 510k:

    PMA is the most stringent regulatory category and must contain sufficient valid scientific evidence to assure that the device is safe and effective for its intended use.

    A 510k is a premarket submission made to FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, substantially equivalent, to a legally marketed device and is not subject to premarket approval.

    Knock-off products are almost exclusively 510k approvals, and thus take the less stringent path to market.

    The fact of the matter is that a single complication arising from a failed staple line will likely cost the hospital more (in re-admitting cost and liability payments) than they are saving by purchasing aftermarket reloads. Some will be willing to roll the dice, but I suspect that most will not.
     
  14. anonymous

    anonymous Guest


    Thanks for the lesson fukstick. That some pretty 101 level stuff.

    Unfortunately you are incomplete in understanding the 510k as a track for both new and "equivalent" products.

    It is still an FDA clearance to market. You can slander and call them "aftermarket" all you want but they are deemed functionally equivalent. I don't see a pile of lawsuits I've people plugging conmed or megadyne pads and pencils into valleylab boxes. (Maybe with the FT10 though and the flamethrower anomaly.)

    There is not a product in the MITG bag that is not a 510k clearance.
     
  15. anonymous

    anonymous Guest

    Again, the clinical and legal ramifications of an adverse event from using an off-brand staple load with an OEM handle are significant. To offer up bovie pencils as an equivalent example is either naive or disingenuous.
     
  16. anonymous

    anonymous Guest


    Good lord you sound like our inept marketing group. We see a challenge on the horizon and the reaction is to stick our heads in the sand and characterize the threat as "off-market" or substandard. That strategy didn't work so well with trocars, reprocessed ligasure, or pads and pencils. FUD is not a strategy, it is a tactic.


    What you are not grasping is that this is an approved medical device with the same regulatory clearance as Tristaple, Signia or TRS. Aeon has its own handles that will fire their reloads but are also compatible with ALL Tristaple configurations.

    Their line of reloads fire on AEON handles but are also forward and backward compatible with Ultra, Legacy and Signia.

    Naivete lies in the lap of those think using fear, uncertainty and doubt is a long term strategy for dealing with market disruptors.
     
  17. anonymous

    anonymous Guest

    LOL! POS knock-off staplers from Aeon want to play with the big boys. Best take that shit to South America where you can kill patients with impunity. That shit won’t fly around here. SAD!
     
  18. anonymous

    anonymous Guest


    DUET
     
  19. anonymous

    anonymous Guest